REQUEST A DEMO
Total
USD $0.00
Search more companies

Clinirem Sp. z o.o. (Poland)

Main Activities: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Secondary Activities: Other Information Services | Computer Systems Design and Related Services | Ambulatory Health Care Services
Full name: Clinirem Sp. z o.o. Profile Updated: May 26, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English & Polish Download a sample report

Clinirem Sp. z o.o. is a company in Poland, with a head office in Lublin. It operates in the Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) industry. The company was established on January 24, 2019. Its’ total assets recorded a growth of 10467.66%.

Headquarters
Ul. Tadeusza Szeligowskiego 8/73
Lublin; Lubelskie; Postal Code: 20-883

Contact Details: Purchase the Clinirem Sp. z o.o. report to view the information.

Website: http://www.clinirem.com

Basic Information
Outstanding Shares:
Purchase the Clinirem Sp. z o.o. report to view the information.
Registered Capital:
Purchase the Clinirem Sp. z o.o. report to view the information.
Incorporation Date:
January 24, 2019
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
Management Board Member
Ownership Details
Purchase this report to view the information.
95%
Company Performance
Financial values in the chart are available after Clinirem Sp. z o.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Operating profit (EBIT)
N/A
Net Profit (Loss) for the Period
N/A
Total assets
10467.66%
Total equity
2955.47%
Return on Equity (ROE)
N/A

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?